Spiracur

About:

Spiracur is a medical device company developing patient-centric wound healing technologies for patients and clinicians.

Website: http://www.spiracur.com

Twitter/X: SpiracurSNaP

Top Investors: Kleiner Perkins, Maverick Ventures, New Leaf Venture Partners, Pinnacle Ventures, DeNovo Ventures

Description:

Spiracur Inc. is a privately held medical device company focused on the development of innovative wound healing technologies. Spiracur was founded out of the Stanford Biodesign Innovation Program in 2007. Its first product, the SNaP Wound Care System, grew out of the notion that current negative pressure wound therapies were too cumbersome for patients and clinicians. Spiracur strives to develop products that are truly patient-centric.

Total Funding Amount:

$75.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2007-01-01

Contact Email:

webmaster(AT)spiracur.com

Founders:

Kenton D. Fong

Number of Employees:

101-250

Last Funding Date:

2014-11-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai